These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6541067)

  • 1. Comparison between diurnal changes and changes induced by hydrocortisone and epinephrine in circulating myeloid progenitor cells (CFU-GM) in man.
    Morra L; Ponassi A; Caristo G; Bruzzi P; Bonelli A; Zunino R; Parodi GB; Sacchetti C
    Biomed Pharmacother; 1984; 38(3):167-70. PubMed ID: 6541067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between blood granulocyte progenitor cells and polymorphonuclear leukocytes. A tentative pathophysiological subgrouping of neutropenic and neutrophilic patients.
    Ponassi A; Morra L; Mela GS; Caristo G; Parodi GB; Sacchetti C
    Biomed Pharmacother; 1983; 37(6):293-7. PubMed ID: 6671134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of colony-forming cells (CFU-C) into the peripheral blood of man by hydrocortisone.
    Morra L; Ponassi A; Parodi GB; Caristo G; Bruzzi P; Sacchetti C
    Biomedicine; 1981 Jul; 35(3):87-90. PubMed ID: 7272426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia.
    Sagaster V; Jäger E; Weltermann A; Schwarzinger I; Gisslinger H; Lechner K; Geissler K; Oehler L
    Haematologica; 2003 Nov; 88(11):1204-12. PubMed ID: 14607748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
    Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
    Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma].
    Ohler L; Scholten C; Reiter E; Tiefengraber E; Jäger U; Strobl H; Lechner K; Höcker P; Geissler K
    Wien Klin Wochenschr; 1993; 105(20):580-4. PubMed ID: 7505076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
    Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
    Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
    Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
    Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variation of circulating human myeloid progenitor cells.
    Ross DD; Pollak A; Akman SA; Bachur NR
    Exp Hematol; 1980 Aug; 8(7):954-60. PubMed ID: 16398029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducing effects of macrophage stimulating protein on the expansion of early hematopoietic progenitor cells in liquid culture.
    Ma LX; Huang YH; Cheng LM; Lei J; Wang QR
    Chin Med J (Engl); 2007 Jul; 120(13):1192-7. PubMed ID: 17637252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.